Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/15/2010CN101918026A Modified insulin polypeptides and their uses
12/15/2010CN101918025A Use of factor VIIa or factor VIIa equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ICH) in a selected subpopulation of ich patients
12/15/2010CN101918024A Methods for inhibition of scarring
12/15/2010CN101918023A Methods for the inhibition of scarring
12/15/2010CN101918022A Activin receptor-like kinase-1 compositions and methods of use
12/15/2010CN101918021A Methods of treating urogenital-neurological disorders using modified clostridial toxins
12/15/2010CN101918020A Modified IL-4 mutein receptor antagonists
12/15/2010CN101918019A Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
12/15/2010CN101918018A Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
12/15/2010CN101918009A Composition for improving liver metabolism and diagnostic method
12/15/2010CN101917969A Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
12/15/2010CN101917967A Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
12/15/2010CN101917960A Use of a neurotoxic component of a clostridium botulinum toxin complex to reduce or prevent side effects
12/15/2010CN101917959A Peptide nanoparticles and uses therefor
12/15/2010CN101914561A Fusion protein with antibacterial and repairing function and production method and application thereof
12/15/2010CN101914546A Amphioxus saccharide pattern-recognition molecule Bjfcn1 gene and application thereof
12/15/2010CN101914545A Leucine-rich protein ALM gene of branchiostoma japonicum and application thereof
12/15/2010CN101914476A Deep sea elastase gene as well as preparation method and application thereof
12/15/2010CN101914161A Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof
12/15/2010CN101914150A Polypeptide and use thereof in medicament preparation
12/15/2010CN101914149A Preparation and application of anti-lipid polysaccharide factor with bacteriostatic activity
12/15/2010CN101914143A HIV-1 membrane fusion inhibitor and application thereof
12/15/2010CN101914140A Scorpion source antivirus active polypeptide and application thereof
12/15/2010CN101914135A Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof
12/15/2010CN101912602A Application of ricinus agglutinin 120 to the resistance against influenza A virus
12/15/2010CN101912601A Stabilised solid compositions of factor VII polypeptides
12/15/2010CN101912600A Method for improving stability of insulin in solution
12/15/2010CN101912599A Application of recombinant human interleukin 15 in preparing medicament for treating malignant ascitic tumor
12/15/2010CN101912598A Method for preparing brain protein hydrolysate for injection and preparation thereof
12/15/2010CN101912424A Preparation method of red yeast rice containing Bacillus natto
12/15/2010CN101912421A Methods and compositions concerning poxviruses and cancer
12/15/2010CN101912355A Recombinant human interleukin-1 receptor antagonist in-situ gel
12/15/2010CN101632634B N(2)-L-alanyl-L-glutamine liposome injection and preparation method thereof
12/15/2010CN101215325B Antibiotic peptides, preparation method and application thereof
12/15/2010CN101099859B New use of leuprorelin acetate in delaying senility and preventing climacteric syndrome
12/15/2010CN101068917B Composition based on arthrospira and its application
12/15/2010CN101068564B Antitumor combinations containing a vegf inhibitor and 5fu or one of its derivatives
12/15/2010CN101062059B Method for preparing jumbuck thymosin
12/15/2010CN101003574B Recombined expression of peptide for lowering blood sugar in long acting, and application in medication for treating diabetes
12/14/2010USRE41996 Composition and methods for enhancing receptor-mediated cellular internalization
12/14/2010US7851607 Expression vector comprising nucleotide sequences coding porcine reproductive and respiratory syndrome polypeptide for use in generating vaccine to prevent viral infection; immunotherapy
12/14/2010US7851604 comprising bromodomain successfully isolated from a human testis cDNA library using primers prepared based on an EST sequence; for diagnosis and treatment of cancer
12/14/2010US7851603 Nucleotide sequences coding mitogenic racemase for use diagnostic probe in detection and prevention of parasite infection; immunotherapy
12/14/2010US7851599 Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine
12/14/2010US7851598 Receptor modulators
12/14/2010US7851596 Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides
12/14/2010US7851594 Human cytokine receptor
12/14/2010US7851593 Binding proteins as biosensors
12/14/2010US7851592 Recombinant check point kinase for use in identifying modulator for use in treatment and prevention of cell proliferative disorders
12/14/2010US7851591 peptide that binds to a human major histocompatibility complex class I A molecule; for treating a patient that has or is at risk of having a cell that expresses telomerase catalytic subunit (hTERT)
12/14/2010US7851589 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
12/14/2010US7851588 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders; (cyclo 31-34)[Ac-Pro4,D-Phe12,Nle18,21,Glu31,Lys34]-sucker urotensin
12/14/2010US7851586 Peptides for activation and inhibition of δPKC
12/14/2010US7851509 Polymorphs of suberoylanilide hydroxamic acid
12/14/2010US7851486 peripheral arterial occlusive disease (PAOD); prophylaxis of myocardial infarction by administering an agent that inhibits leukotriene synthesis in vivo for example (R)-(+)-alpha-cyclopentyl-4-(2-quinolinylmethoxy)-Benzeneacetic acid, BAY-X-1005
12/14/2010US7851455 determining the percentage of the cells in a vertebrate tumor that are hypoxic, comprising quantifying MN/CA9 gene expression product in a tissue sample taken from said tumor
12/14/2010US7851449 peptide lysyl-glutamyl-asparagine acid capable of enhancing capillaries resistance; for treatment of purpura senilis; normalization of blood microcirculation
12/14/2010US7851448 adminstering a polypeptide optionally having one conservative amino acid substitutions, which can be used to treat, prevent, and modulate metabolic condition in plants
12/14/2010US7851447 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve
12/14/2010US7851446 Use of therapeutic human albumin for treatment of alzheimer'S disease
12/14/2010US7851445 Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use
12/14/2010US7851444 χ-conotoxin peptides (-1)
12/14/2010US7851443 Combretastatin A4, ombrabulin hydrochloride, or 1-(3-amino-4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene with VEGF inhibitor fusion protein VEGF Trap
12/14/2010US7851442 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin)
12/14/2010US7851441 isolation of low molecular weight proteins from connective tissue of animals, by dissolving in an aqueous solution of alkali compounds, for use in foods and drugs such as anticoagulants or anticholesterol agents
12/14/2010US7851440 Peptides with affinity for a phospholipid and uses
12/14/2010US7851439 useful in interfering with the life cycle of bacteria and in treating or preventing a bacterial infection
12/14/2010US7851438 PEGylated with desired N-glycoforms; ease of administration; pharmacokinetics, bioavailability; lower cost biosynthesis technique utilizing lower eukaryotic cells
12/14/2010US7851437 monoclonal antibody conjugated with peptide drug such as dolastatin derivative
12/14/2010US7851436 Contacting a tumor, endolthelial or osteoclast cell with the amino propeptide having the amino acid sequence encoded by exons 3-8 of the nucleic acid sequence; angiogenesis inhibitors; antitumor, -carcinogenic, -metastasis agents; administering with a therapeutic agent; detachment-mediated
12/14/2010US7851435 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
12/14/2010US7851433 Method of purifying TFPI and TFPI analogs
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7851164 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders
12/14/2010US7850995 having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery
12/14/2010US7850980 Chlamydia OMP antigen
12/14/2010US7850976 Insulin resistance improving agents
12/14/2010US7850974 Using sequences infomation to identify microbial surface components recognizing adhesive matrix molecules (MSCRAMM proteins) in order to diagnose, treat and prevent bacterial infection
12/14/2010US7850973 Amino acid composition comprising a multivalent branched multiple antigen peptide (MAP) linked to a carrier for induction of immune response to amyloid beta deposition in brain; treatment and prevention of nervous system disorders
12/14/2010US7850972 Immunogenic cryptosporidium parvum polypeptide for use in treatment and prevention of protozoal infection
12/14/2010US7850971 PSMA antibodies and protein multimers
12/14/2010US7850970 Bacrtericides; viricides; administering antitrypsin; gramnedative, grampositive bacteria; anthrax
12/14/2010US7850969 Apparatus for reducing secretory activity of leukocytes which comprises plastic housing, carriers, blood inlet/outlet nozzles and an antibody against Fas (CD95) that is linked to the carrier
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850967 Method of treating a patient having an autoimmune disorder by administering an antibody that binds human BAFFR
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010US7850959 Methods and compositions for treating conditions involving abnormal angiogenesis
12/14/2010US7850957 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells
12/14/2010US7850956 Immunization by inoculation of DNA transcription unit
12/14/2010CA2504755C Carbohydrate-based synthetic vaccines for hiv
12/14/2010CA2444578C Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension
12/14/2010CA2417484C Elongase genes and uses thereof
12/14/2010CA2385132C Process for producing ubiquinone-10
12/14/2010CA2309633C Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
12/14/2010CA2308116C Low-toxicity human interferon-alpha analog
12/14/2010CA2285937C Modified proteins which bind extracellular matrix components
12/14/2010CA2252560C Treatment of partial growth hormone insensitivity syndrome
12/14/2010CA2247989C C-c ckr-5,cc-chemokines receptor, derivatives thereof and their uses
12/14/2010CA2207615C Spray dried erythropoietin
12/14/2010CA2205007C Antibody against human interleukin-5 receptor .alpha. chain
1 ... 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 ... 3163